370 related articles for article (PubMed ID: 27938483)
21. Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.
Nabavi SM; Karimi SH; Arab L; Sanjari L; Mardpour S; Azimian V; Jarughi N; Ghaheri A; Hosseini SE; Aghdami N; Vosough M
Cell J; 2021 Dec; 23(7):772-778. PubMed ID: 34979067
[TBL] [Abstract][Full Text] [Related]
22. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
Prabhakar S; Marwaha N; Lal V; Sharma RR; Rajan R; Khandelwal N
Neurol India; 2012; 60(5):465-9. PubMed ID: 23135021
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial.
Mazzini L; Ferrero I; Luparello V; Rustichelli D; Gunetti M; Mareschi K; Testa L; Stecco A; Tarletti R; Miglioretti M; Fava E; Nasuelli N; Cisari C; Massara M; Vercelli R; Oggioni GD; Carriero A; Cantello R; Monaco F; Fagioli F
Exp Neurol; 2010 May; 223(1):229-37. PubMed ID: 19682989
[TBL] [Abstract][Full Text] [Related]
24. The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate.
Koh SH; Baik W; Noh MY; Cho GW; Kim HY; Kim KS; Kim SH
Exp Neurol; 2012 Jan; 233(1):472-80. PubMed ID: 22119626
[TBL] [Abstract][Full Text] [Related]
25. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
[TBL] [Abstract][Full Text] [Related]
26. A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials.
Chen BK; Staff NP; Knight AM; Nesbitt JJ; Butler GW; Padley DJ; Parisi JE; Dietz AB; Windebank AJ
Transfusion; 2015 May; 55(5):1013-20. PubMed ID: 25413276
[TBL] [Abstract][Full Text] [Related]
27. Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis.
De Marchi F; Mareschi K; Ferrero I; Cantello R; Fagioli F; Mazzini L
Cytotherapy; 2023 Aug; 25(8):798-802. PubMed ID: 36931995
[TBL] [Abstract][Full Text] [Related]
28. Stem cell treatment in Amyotrophic Lateral Sclerosis.
Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
[TBL] [Abstract][Full Text] [Related]
29. β-PIX is critical for transplanted mesenchymal stromal cell migration.
Koh SH; Huh YM; Noh MY; Kim HY; Kim KS; Lee ES; Ko HJ; Cho GW; Yoo AR; Song HT; Hwang S; Lee K; Haam S; Frank JA; Suh JS; Kim SH
Stem Cells Dev; 2012 Jul; 21(11):1989-99. PubMed ID: 22087847
[TBL] [Abstract][Full Text] [Related]
30. Functional Restoration of Amyotrophic Lateral Sclerosis Patient-Derived Mesenchymal Stromal Cells Through Inhibition of DNA Methyltransferase.
Oh YS; Kim SH; Cho GW
Cell Mol Neurobiol; 2016 May; 36(4):613-20. PubMed ID: 26210997
[TBL] [Abstract][Full Text] [Related]
31. Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: Variation across amyotrophic lateral sclerosis clinical phenotypes.
Elamin EM; Wilson CS; Sriaroon C; Crudup B; Pothen S; Kang YC; White KT; Anderson WM
Int J Clin Pract; 2019 Jan; 73(1):e13257. PubMed ID: 30230161
[TBL] [Abstract][Full Text] [Related]
32. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
33. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
Pal R; Venkataramana NK; Bansal A; Balaraju S; Jan M; Chandra R; Dixit A; Rauthan A; Murgod U; Totey S
Cytotherapy; 2009; 11(7):897-911. PubMed ID: 19903102
[TBL] [Abstract][Full Text] [Related]
35. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study.
Blanquer M; Moraleda JM; Iniesta F; Gómez-Espuch J; Meca-Lallana J; Villaverde R; Pérez-Espejo MÁ; Ruíz-López FJ; García Santos JM; Bleda P; Izura V; Sáez M; De Mingo P; Vivancos L; Carles R; Jiménez J; Hernández J; Guardiola J; Del Rio ST; Antúnez C; De la Rosa P; Majado MJ; Sánchez-Salinas A; López J; Martínez-Lage JF; Martínez S
Stem Cells; 2012 Jun; 30(6):1277-85. PubMed ID: 22415951
[TBL] [Abstract][Full Text] [Related]
36. Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):86-91. PubMed ID: 27915482
[TBL] [Abstract][Full Text] [Related]
37. The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy - a perspective on cell biological mechanisms.
Tang BL
Rev Neurosci; 2017 Oct; 28(7):725-738. PubMed ID: 28599400
[TBL] [Abstract][Full Text] [Related]
38. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.
Deda H; Inci MC; Kürekçi AE; Sav A; Kayihan K; Ozgün E; Ustünsoy GE; Kocabay S
Cytotherapy; 2009; 11(1):18-25. PubMed ID: 19012065
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.
Mazzini L; Mareschi K; Ferrero I; Miglioretti M; Stecco A; Servo S; Carriero A; Monaco F; Fagioli F
Cytotherapy; 2012 Jan; 14(1):56-60. PubMed ID: 21954839
[TBL] [Abstract][Full Text] [Related]
40. Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis.
Sufit RL; Ajroud-Driss S; Casey P; Kessler JA
Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):269-278. PubMed ID: 28166654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
